Effect of a cholinesterase inhibitor on cardiac acetylcholine and tissue glycogen contents in anesthetized dogs.
D000109:Acetylcholine / Q000378:metabolism*; D000315:Adrenalectomy; D000818:Animals; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D002800:Cholinesterase Inhibitors; D002802:Cholinesterases / Q000097:blood; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D006003:Glycogen / Q000378:metabolism; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology
D001786:Blood Glucose; D002800:Cholinesterase Inhibitors; D006003:Glycogen; D010830:Physostigmine; D011433:Propranolol; D002802:Cholinesterases; D000109:Acetylcholine